Femoral hernia

K11_FEMHER

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 K41
  • Hospital discharge: ICD-9 5510|552A|5530
  • Hospital discharge: ICD-8 5510
  • Cause of death: ICD-10 K41
  • Cause of death: ICD-9 5510|552A|5530
  • Cause of death: ICD-8 5510

2 out of 7 registries used, show all original rules.

1709

4. Check minimum number of events

None

1709

5. Include endpoints

None

1709

6. Filter based on genotype QC (FinnGen only)

1709

Control definitions (FinnGen only)

Control exclude
K11_HERNIA

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
K40-K46
Name in latin
Hernia femoralis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 16909 10051 6717
Only index persons 13103 7980 5123
Unadjusted period prevalence (%)
Whole population 0.25 0.29 0.19
Only index persons 0.26 0.29 0.20
Median age at first event (years)
Whole population 57.75 58.94 55.78
Only index persons 54.00 54.97 52.48

-FinnGen-

Key figures

All Female Male
Number of individuals 1709 945 764
Unadjusted period prevalence (%) 0.33 0.32 0.34
Median age at first event (years) 52.87 50.92 55.27

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1532
Matched controls
15319
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K41.9
ICD-10 Finland
Unilateral or unspecified femoral hernia, without obstruction or gangrene
+∞
323.0
641
*
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
185.6
323.0
542
45
6123
FHL
Radical surgery
1188.9
323.0
364
*
5530A
ICD-9 Finland
Other hernia of abdominal cavity without mention of obstruction or gangrene, Femoral hernia
+∞
323.0
396
*
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
698.3
323.0
331
6
K41.3
ICD-10 Finland
Unilateral or unspecified femoral hernia, with obstruction, without gangrene
+∞
239.0
223
*
55100
ICD-8 Finland
Other hernia of abdominal cavity without mention of obstruction, Femoral
+∞
165.7
156
*
JAC10
NOMESCO Finland
Repair of femoral hernia
1622.9
151.7
145
*
JAC30
NOMESCO Finland
Repair of femoral hernia using prosthetic material
+∞
144.1
136
*
JAB11
NOMESCO Finland
Laparoscopic repair of inguinal hernia
256.5
138.5
140
6
K40.3
ICD-10 Finland
Unilateral or unspecified inguinal hernia, with obstruction, without gangrene
1194.4
115.2
111
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
39.3
94.6
120
33
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
67.5
93.0
107
17
6124
FHL
Radical cutting and plastic with foreign material
841.8
82.3
80
*
55099
ICD-8 Finland
Inguinal hernia without mention of obstruction
+∞
82.0
78
*
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
70.6
81.4
93
14
JAC11
NOMESCO Finland
Laparoscopic repair of femoral hernia
+∞
69.3
66
*
K40.2
ICD-10 Finland
Bilateral inguinal hernia, without obstruction or gangrene
127.6
68.5
73
6
JAB10
NOMESCO Finland
Repair of inguinal hernia
226.0
63.6
65
*
5509B
ICD-9 Finland
Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,LATERALIS (SCROT]
+∞
52.4
50
*
K41.2
ICD-10 Finland
Bilateral femoral hernia, without obstruction or gangrene
+∞
50.3
48
*
K41.4
ICD-10 Finland
Unilateral or unspecified femoral hernia, with gangrene
+∞
47.1
45
*
D89
ICPC
Inguinal hernia
51.8
46.1
55
11
K41.0
ICD-10 Finland
Bilateral femoral hernia, with obstruction, without gangrene
+∞
44.0
42
*
5509A
ICD-9 Finland
Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,MEDIALIS]
+∞
42.9
41
*
5510A
ICD-9 Finland
Other hernia of abdominal cavity, with gangrene, Femoral hernia with gangrene
+∞
42.9
41
*
JAB12
NOMESCO Finland
Laparoscopic repair of inguinal hernia, TEP
+∞
42.9
41
*
JAF10
NOMESCO Finland
Repair of umbilical hernia
38.4
41.2
52
14
6129
FHL
Other measure in this category
+∞
40.8
39
*
K40
ICD-10 Finland
Inguinal hernia
21.1
34.5
51
25
JAF30
NOMESCO Finland
Repair of umbilical hernia using prosthetic material
89.5
31.8
35
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.3
31.1
327
1596
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
47.3
30.7
37
8
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
29.6
537
3305
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
9.6
29.5
61
66
JAC12
NOMESCO Finland
Laparoscopic repair of femoral hernia, TEP
+∞
29.3
28
*
K42.0
ICD-10 Finland
Umbilical hernia with obstruction, without gangrene
254.1
24.7
25
*
6125
FHL
Residual surgery, can be reported as a side effect
+∞
23.0
22
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
223.0
21.6
22
*
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
+∞
20.9
20
*
N02BE01
ATC
paracetamol; systemic, rectal
1.9
20.0
1273
11104
5531A
ICD-9 Finland
Other hernia of abdominal cavity without mention of obstruction or gangrene, Umbilical hernia
+∞
19.8
19
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
19.2
419
2665
K41
ICD-10 Finland
Femoral hernia
192.2
18.6
19
*
JFB00
NOMESCO Finland
Partial resection of small intestine
6.7
18.5
47
72
ZXA00
NOMESCO Finland
Right side
1.7
16.3
422
2803
JAD10
NOMESCO Finland
Repair of incisional hernia
48.0
16.0
19
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
15.9
616
4554
R03AC02
ATC
salbutamol; inhalant
1.6
15.4
702
5392
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
14.7
310
1931
K40.4
ICD-10 Finland
Unilateral or unspecified inguinal hernia, with gangrene
+∞
14.6
14
*
5509D
ICD-9 Finland
Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,RECIDIVANS]
+∞
14.6
14
*
ZXA05
NOMESCO Finland
Left side
1.7
14.3
385
2575
UJF32
NOMESCO Finland
Coloscopy
1.7
14.1
373
2479
JAH01
NOMESCO Finland
Laparoscopy
3.4
13.9
67
203
WX320
NOMESCO Finland
Spinalanesthesy
1.7
13.6
332
2153
5509X
ICD-9 Finland
Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,ALIA SEU NUD]
+∞
13.6
13
*
JAB96
NOMESCO Finland
Other repair of inguinal hernia
+∞
13.6
13
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
13.1
372
2515
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
12.8
157
805
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
12.7
626
4822
M79.6
ICD-10 Finland
Pain in limb
1.5
12.7
487
3542
JAC96
NOMESCO Finland
Other repair of femoral hernia
+∞
12.5
12
*
S18
ICPC
Laceration/cut
1.5
12.5
582
4424
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
12.4
382
2628
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
12.3
619
4778
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
12.3
268
1677
SPAT1263
SPAT
Sampling
1.5
12.2
599
4597
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
12.1
280
1785
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
12.0
250
1546
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
11.6
110
501
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
11.6
422
3021
JAB97
NOMESCO Finland
Other laparoscopic repair of inguinal hernia
+∞
11.5
11
*
JAF11
NOMESCO Finland
Laparoscopic repair of umbilical hernia
120.9
11.4
12
*
SPAT1153
SPAT
Removal of sutures
1.5
11.3
456
3338
A02BC01
ATC
omeprazole; systemic
1.5
11.3
403
2870
B01AB05
ATC
enoxaparin; parenteral
1.5
11.2
441
3208
J45.1
ICD-10 Finland
Nonallergic asthma
2.3
11.0
106
487
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
11.0
114
544
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
11.0
255
1624
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
43.6
10.9
13
*
A02BC02
ATC
pantoprazole; systemic
1.4
10.7
906
7682
A02BC03
ATC
lansoprazole; oral
1.5
10.7
409
2953
J01AA02
ATC
doxycycline; systemic
1.5
10.6
1100
9702
55110
ICD-8 Finland
Other hernia of abdominal cavity without mention of obstruction, Umbilical
+∞
10.4
10
*
JAB91
NOMESCO Finland
Repair of recurrent inguinal hernia, endoscopy
+∞
10.4
10
*
WX704
NOMESCO Finland
Intubation
2.2
10.3
102
476
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.9
10.2
148
807
N03AX12
ATC
gabapentin; oral
1.7
10.2
216
1337
A02BC05
ATC
esomeprazole; systemic
1.5
10.2
533
4108
G04CA02
ATC
tamsulosin; oral
1.6
10.0
327
2270
M54.5
ICD-10 Finland
Low back pain
1.5
10.0
418
3070
SPAT1301
SPAT
No procedures
1.5
9.9
449
3357
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
9.8
144
789
J01CA04
ATC
amoxicillin; systemic
1.4
9.6
1079
9551
D91
ICPC
Abdominal hernia other
15.1
9.5
15
10
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
9.5
533
4149
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
9.4
209
1308
J01MA02
ATC
ciprofloxacin; systemic
1.4
9.4
548
4290
J01DA01
ATC
[U] cefalexin; systemic
1.4
9.4
863
7341
6122
FHL
Removal of the hernia bag without plastic
+∞
9.4
9
*
JAE10
NOMESCO Finland
Repair of epigastric hernia
+∞
9.4
9
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
9.3
194
1193
R51.80
ICD-10 Finland
Headache
1.8
9.3
174
1038
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
9.2
126
676
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
9.0
235
1540
J01DB01
ATC
cefalexin; oral
1.4
8.9
1118
10013
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
8.8
208
1328
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
8.8
252
1689
R03BA05
ATC
fluticasone; inhalant
1.6
8.8
233
1532
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
8.6
565
4504
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.8
8.6
146
843
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
8.6
470
3629
WX110
NOMESCO Finland
Local anesthesy
1.4
8.5
863
7407
K46.9
ICD-10 Finland
Unspecified abdominal hernia without obstruction or gangrene
27.7
8.5
11
*
K59.09
ICD-10 Finland
Constipation, unspecified
2.1
8.5
91
441
PHD99
NOMESCO Finland
Resection of other vein
2.1
8.4
95
472
K41.1
ICD-10 Finland
Bilateral femoral hernia, with gangrene
+∞
8.3
8
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.2
8.3
85
402
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.8
8.3
132
745
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
8.0
273
1904
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
2.1
7.9
92
462
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.5
7.9
303
2172
WX402
NOMESCO Finland
General anaesthesia
1.6
7.9
200
1298
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
7.8
150
901
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
7.7
182
1161
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
5.3
7.7
22
42
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.5
7.7
291
2076
H02AB06
ATC
prednisolone; systemic
1.4
7.7
635
5239
WX702
NOMESCO Finland
Supraglottic ventilation device
2.3
7.7
69
311
SPAT1260
SPAT
Consultation of another employee
1.5
7.7
240
1641
R06.0
ICD-10 Finland
Dyspnoea
1.5
7.6
331
2433
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
7.6
155
950
R96
ICPC
Asthma
1.9
7.5
113
625
ZXA10
NOMESCO Finland
Bilateral
1.5
7.5
251
1744
L17
ICPC
Foot/toe symptom/complaint
1.5
7.5
328
2414
A06AD11
ATC
lactulose; oral
1.6
7.4
215
1443
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
7.4
203
1342
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
7.4
118
669
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
7.4
332
2455
R52.2
ICD-10 Finland
Other chronic pain
2.7
7.4
48
182
JBB01
NOMESCO Finland
Laparoscopic repair of paraoesophageal hernia
+∞
7.3
7
*
5532A
ICD-9 Finland
Other hernia of abdominal cavity without mention of obstruction or gangrene, Ventral hernia [incisional][HERNIA VENTRALIS SINE OBSTRUCTIONE ET GANGRAENA]
+∞
7.3
7
*
M01AB05
ATC
diclofenac; systemic, rectal
1.3
7.2
878
7663
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
7.2
119
681
M02AA07
ATC
piroxicam; topical
1.4
7.1
520
4189
M01AB55
ATC
diclofenac, combinations; oral
1.9
7.1
104
571
N06AA09
ATC
amitriptyline; systemic
1.7
7.1
133
794
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
7.1
413
3203
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
7.0
331
2465
N81.6
ICD-10 Finland
Rectocele
2.0
7.0
87
450
XG410
NOMESCO Finland
Flow-volume spirometry
2.4
7.0
58
250
WX725
NOMESCO Finland
Noninvasive ventilation
2.3
6.9
61
273
XKD00
NOMESCO Finland
Uroflowmetry
1.5
6.8
217
1487
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
6.8
208
1417
UKC02
NOMESCO Finland
Cystoscopy
1.5
6.7
227
1577
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
6.7
164
1055
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
6.7
225
1562
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
1.9
6.6
94
510
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.9
6.6
88
466
L16
ICPC
Ankle symptom/complaint
1.8
6.6
121
715
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
3.8
6.6
26
70
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.8
6.6
26
70
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
6.6
211
1450
P01AB01
ATC
metronidazole; oral, rectal
1.4
6.6
485
3903
R42
ICD-10 Finland
Dizziness and giddiness
1.4
6.6
293
2162
R13
ICD-10 Finland
Dysphagia
1.9
6.6
88
471
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
6.5
344
2616
WX720
NOMESCO Finland
Own respiration
2.4
6.5
52
222
UJD02
NOMESCO Finland
Gastroscopy
2.1
6.4
70
344
SPAT1312
SPAT
General health counselling
1.4
6.4
399
3117
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
70.1
6.4
7
*
A02BA02
ATC
ranitidine; systemic
1.4
6.4
279
2046
N81.1
ICD-10 Finland
Cystocele
1.9
6.3
90
491
R52.9
ICD-10 Finland
Pain, unspecified
1.8
6.3
110
643
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
6.3
222
1558
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.8
6.3
101
576
JAC97
NOMESCO Finland
Other laparoscopic repair of femoral hernia
+∞
6.3
6
*
K40.0
ICD-10 Finland
Bilateral inguinal hernia, with obstruction, without gangrene
+∞
6.3
6
*
JAB93
NOMESCO Finland
Repair of recurrent inguinal hernia, implantation
+∞
6.3
6
*
D06
ICPC
Abdominal pain localized other
1.8
6.3
99
562
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
6.2
229
1623
M01AC06
ATC
meloxicam; systemic, rectal
1.3
6.2
470
3796
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
6.2
137
861
PHD76
NOMESCO Finland
Resection of long saphenous vein
2.0
6.1
70
352
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
6.1
508
4156
N05BB01
ATC
hydroxyzine; systemic
2.0
6.1
78
410
M01AX17
ATC
nimesulide; oral
1.4
6.1
327
2493
C07AB07
ATC
bisoprolol; oral
1.3
6.1
669
5697
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
2.5
6.1
43
172
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
6.0
116
699
J02AC01
ATC
fluconazole; systemic
1.3
6.0
463
3744

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
857
6312
1.72
25.97
4.5
4.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
583
4203
1.59
17.04
2.9
2.4
u/l
55.6
57.4
0.71
534
3852
(3013826) Glucose [Moles/volume] in Serum or Plasma
985
8057
1.53
15.81
6.1
4.6
mmol/l
6.7
6.8
1.93
927
7565
(3016502) Oxygen saturation in Arterial blood
241
1408
1.83
15.35
8.5
7.4
%
95.3
95.3
0.01
233
1353
(3032080) INR in Blood by Coagulation assay
736
5804
1.47
13.22
11.5
10.0
inr
1.3
1.3
0.05
186
1682
(3013707) Erythrocyte sedimentation rate by Westergren method
1153
9934
1.49
13.06
4.7
4.0
mm/h
12.0
13.6
3.57
1076
9113
(3002173) Hemoglobin [Mass/volume] in Arterial blood
218
1297
1.78
12.98
9.2
7.9
g/l
123.2
120.8
0.91
210
1243
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
878
7183
1.46
12.92
6.1
6.0
umol/l
11.0
11.6
1.45
826
6794
(3031040) Bacteria [#/volume] in Urine by Automated count
1063
9041
1.46
12.62
5.6
4.7
e6/l
2088.4
1850.9
0.07
23
159
(3044640) Blood type and Crossmatch panel - Blood
570
4309
1.48
12.51
2.5
2.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1205
10558
1.48
11.86
8.1
7.3
u/l
77.6
79.6
0.78
1131
9859
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
787
6384
1.43
11.68
7.1
5.7
mmol/l
1.2
1.2
0.98
703
5710
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
135
713
1.97
11.65
11.4
10.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
250
1591
1.67
11.63
8.5
7.0
kpa
5.1
5.1
0.29
240
1508
(3024561) Albumin [Mass/volume] in Serum or Plasma
753
6065
1.43
11.60
5.2
4.5
g/l
34.9
35.1
0.45
698
5601
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
855
7051
1.43
11.52
7.9
6.6
mmol/l
1.2
1.2
0.41
728
5872
(3003396) Base excess in Arterial blood by calculation
249
1588
1.66
11.48
8.5
7.0
mmol/l
1.1
1.1
0.02
197
1229
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1448
13232
1.62
11.37
19.3
15.0
mg/l
26.0
25.3
0.32
1212
10534
(3027801) Oxygen [Partial pressure] in Arterial blood
249
1592
1.66
11.36
8.5
7.0
kpa
11.8
11.9
0.20
239
1511
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
571
4383
1.45
11.34
3.3
3.0
ng/l
1591.4
1571.5
0.04
502
3779
(3015736) pH of Urine
643
5058
1.43
11.15
4.4
3.5
—
5.6
—
0
6
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
689
5489
1.43
11.14
4.6
3.8
ng/l
43.8
57.3
0.47
505
4028
(3037467) Urinalysis macro (dipstick) panel - Urine
1075
9343
1.41
10.10
5.1
4.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
791
6534
1.39
10.04
4.5
3.8
estimate
0.0
0.0
0.00
137
1257
(3013650) Neutrophils [#/volume] in Blood by Automated count
909
7713
1.38
9.66
8.7
8.8
e9/l
4.3
4.2
0.39
804
6700
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
465
3536
1.43
9.38
2.4
2.1
mg/l
3.2
3.0
0.50
400
2980
(3009261) Glucose [Presence] in Urine by Test strip
795
6626
1.37
9.31
4.6
3.8
estimate
0.0
0.0
0.80
139
1237
(3019150) Specific gravity of Urine by Refractometry
391
2886
1.46
9.23
5.6
4.1
kg/l
1.0
1.0
0.10
58
440
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
384
2826
1.46
9.20
1.8
1.7
mg/l
1.3
1.2
0.16
296
2183
(3014007) Fractional oxyhemoglobin in Arterial blood
145
851
1.77
9.00
9.8
9.0
%
93.9
93.7
0.15
145
845
(3014576) Chloride [Moles/volume] in Serum or Plasma
253
1726
1.55
8.71
7.6
6.6
mmol/l
103.6
104.3
1.34
244
1685
(3021601) Nitrite [Presence] in Urine by Test strip
783
6556
1.36
8.70
5.9
5.1
estimate
0.0
0.0
0.50
139
1264
(3001122) Ferritin [Mass/volume] in Serum or Plasma
668
5471
1.36
8.49
3.1
2.7
ug/l
122.8
140.5
0.94
614
4986
(3021960) Folate [Moles/volume] in Serum or Plasma
443
3394
1.41
8.43
1.6
1.6
nmol/l
21.3
20.9
0.19
373
2866
(3007853) Bacteria identified in Skin by Aerobe culture
231
1558
1.56
8.35
1.7
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
325
2361
1.46
8.24
1.8
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
244
1678
1.53
8.07
1.2
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
146
890
1.70
7.94
8.4
6.5
mmol/l
24.5
24.6
0.06
135
823
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
427
3281
1.40
7.92
2.3
2.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
794
6729
1.34
7.86
6.2
5.6
e9/l
1.8
1.9
2.08
694
5857
(3013115) Eosinophils [#/volume] in Blood
800
6794
1.33
7.78
6.4
5.8
e9/l
0.2
0.2
0.20
713
5895
(3019550) Sodium [Moles/volume] in Serum or Plasma
1481
13870
1.51
7.59
22.4
17.5
mmol/l
139.5
139.6
1.28
1455
13477
(3019060) Gas panel - Arterial blood
153
956
1.66
7.58
5.9
4.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1483
13904
1.50
7.44
22.4
17.7
mmol/l
4.0
4.0
0.05
1453
13487
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
359
2709
1.41
7.33
4.8
3.8
ng/l
246.6
400.2
0.87
296
2248
(3006315) Basophils [#/volume] in Blood
772
6569
1.32
7.21
6.3
5.6
e9/l
0.0
0.0
0.10
667
5620
(3023368) Bacteria identified in Blood by Culture
498
3976
1.36
7.20
4.2
4.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
700
5882
1.32
7.13
2.1
2.0
pmol/l
92.8
94.0
0.23
349
3006
(3011397) Hemoglobin [Presence] in Urine by Test strip
397
3080
1.38
6.83
4.9
3.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
766
6547
1.31
6.79
6.2
5.5
e9/l
0.6
0.6
0.43
662
5585
(3014111) Lactate [Moles/volume] in Serum or Plasma
180
1202
1.56
6.79
7.7
6.6
mmol/l
1.2
1.4
2.35
175
1153
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
662
5572
1.31
6.49
2.4
2.2
nmol/l
80.4
78.8
0.76
581
4909
(3029937) Albumin [Presence] in Urine by Test strip
453
3616
1.34
6.44
5.4
4.1
estimate
0.0
0.0
0.40
129
1218
(4010399)
142
911
1.61
6.36
1.5
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
507
4123
1.33
6.33
4.0
3.1
u/l
29.4
33.9
2.25
482
3901
(3018418) pH of Serum or Plasma
517
4218
1.32
6.31
4.2
3.9
ph
7.4
7.4
0.23
82
843
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
924
8163
1.29
6.12
3.4
3.1
u/l
45.1
51.9
1.68
849
7492
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
114
702
1.67
6.01
10.3
9.4
mmol/l
24.4
24.3
0.07
103
658
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
228
1640
1.45
6.00
1.8
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
361
2814
1.36
5.94
1.9
1.8
nmol/l
1175.1
1186.3
0.08
274
2102
(3000991) Gas panel - Venous blood
167
1131
1.53
5.92
9.4
7.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
226
1630
1.45
5.86
1.7
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
258
1910
1.41
5.80
2.3
2.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
202
1433
1.46
5.71
2.8
2.6
umol/l
7.8
8.5
0.13
172
1249
(3047181) Lactate [Moles/volume] in Blood
80
453
1.80
5.68
7.4
5.7
mmol/l
1.4
1.3
0.08
66
388
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
518
4284
1.30
5.60
2.4
2.1
u/l
322.4
196.9
0.41
491
3994
(3018010) Neutrophils/100 leukocytes in Blood
724
6251
1.27
5.58
6.4
5.7
%
58.7
57.9
0.83
679
5811
(3003338) MCHC [Mass/volume]
1176
10780
1.29
5.52
25.8
19.6
g/l
331.5
331.8
0.72
1167
10689
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
818
7179
1.27
5.47
2.8
2.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
166
1145
1.50
5.40
4.9
3.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
600
5078
1.28
5.38
5.2
4.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
377
3004
1.33
5.31
2.8
2.6
e6/l
5.4
5.7
0.20
334
2642
(3015377) Calcium [Moles/volume] in Serum or Plasma
571
4810
1.28
5.30
3.4
3.2
mmol/l
2.3
2.4
0.52
483
4143
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1483
14083
1.40
5.23
12.0
10.5
u/l
23.8
25.3
2.11
1436
13497
(3003458) Phosphate [Moles/volume] in Serum or Plasma
249
1868
1.39
5.16
5.7
5.3
mmol/l
1.0
1.0
0.02
229
1719
(3018677) aPTT in Platelet poor plasma by Coagulation assay
276
2106
1.37
5.16
2.2
2.1
s
29.6
30.0
0.60
266
2043
(3039000) Anion gap in Blood
58
307
1.92
5.11
8.4
6.8
mmol/l
11.3
11.2
0.03
50
268
(3018572) Chloride [Moles/volume] in Blood
58
307
1.92
5.11
8.4
6.8
mmol/l
104.4
105.5
0.87
50
268
(40761511) CBC panel - Blood by Automated count
1445
13682
1.36
5.04
18.5
14.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
256
1939
1.38
5.01
27.6
26.6
inr
1.4
1.4
0.05
28
277
(3002030) Lymphocytes/100 leukocytes in Blood
729
6356
1.26
5.00
6.6
5.9
%
26.3
26.9
0.89
681
5889
(3026008) Bacteria identified in Urine by Culture
537
4517
1.28
4.98
3.7
3.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1101
10072
1.26
4.93
4.3
4.0
pmol/l
15.0
14.9
0.33
990
9037
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1301
12151
1.30
4.89
5.2
4.8
mu/l
1.9
2.1
0.69
1177
10964
(3006504) Eosinophils/100 leukocytes in Blood
709
6176
1.25
4.86
6.6
5.8
%
2.9
2.8
0.26
666
5719
(3018095) Leukocytes [#/volume] in Urine
576
4899
1.27
4.85
3.8
3.7
e6/l
96.7
126.3
0.52
421
3535
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
155
1080
1.48
4.82
2.9
2.7
ml/min/173m2
65.6
62.5
0.57
67
469
(3010813) Leukocytes [#/volume] in Blood
1527
14612
1.42
4.80
27.8
22.1
e9/l
6.8
6.8
0.17
1492
14124
(3024731) MCV [Entitic volume]
1526
14604
1.42
4.76
27.7
22.0
fl
91.6
91.4
0.47
1510
14340
(3019069) Monocytes/100 leukocytes in Blood
711
6208
1.25
4.74
6.9
6.1
%
8.8
8.8
0.01
670
5777
(3035941) MCH [Entitic mass]
1526
14606
1.42
4.74
27.6
22.0
pg
30.4
30.4
0.05
1509
14340
(3026361) Erythrocytes [#/volume] in Blood
1526
14607
1.42
4.73
27.8
22.1
e12/l
4.4
4.4
1.27
1490
14121
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
19
63
3.04
4.67
3.2
2.0
e9/l
0.2
0.2
0.16
19
55
(3000963) Hemoglobin [Mass/volume] in Blood
1526
14612
1.41
4.67
27.9
22.2
g/l
132.9
133.7
1.21
1512
14351
(3007461) Platelets [#/volume] in Blood
1525
14601
1.41
4.67
27.8
22.1
e9/l
245.0
247.4
0.75
1493
14174
(3020891) Body temperature
89
553
1.64
4.59
5.9
4.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
177
1277
1.43
4.59
3.8
2.9
ng/l
188.5
220.6
0.70
157
1174
(3022096) Basophils/100 leukocytes in Blood
688
6002
1.24
4.58
6.5
5.8
%
0.7
0.7
0.24
644
5565
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
19
64
2.99
4.56
3.2
2.0
e6/l
358.8
566.9
0.79
19
55
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
325
2590
1.31
4.52
1.3
1.2
u/ml
1.7
1.6
0.06
78
676
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
111
731
1.55
4.51
2.3
2.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
462
3867
1.27
4.37
3.3
3.1
e6/l
0.4
0.5
0.15
349
2953
(3002582) Erythrocytes [#/volume] in Urine
502
4244
1.26
4.37
3.3
3.2
e6/l
40.9
92.6
1.69
391
3285
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
228
1734
1.36
4.34
9.3
7.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
201
1498
1.39
4.34
3.6
4.0
ug/l
26.5
18.7
0.17
164
1242
(3006576) Bicarbonate [Moles/volume] in Blood
14
40
3.52
4.33
5.5
7.5
mmol/l
25.2
25.2
0.02
14
35
(3007930) Methemoglobin/Hemoglobin.total in Blood
92
586
1.60
4.32
6.5
4.9
%
0.9
0.9
0.29
84
545
(40758558) Short blood count panel - Blood
406
3356
1.28
4.25
6.3
6.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1375
13009
1.29
4.20
4.9
4.7
mmol/l
5.9
6.0
2.19
1249
11678
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
294
2338
1.31
4.13
2.7
2.7
e6/l
0.9
1.3
1.12
167
1333
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
92
593
1.58
4.12
6.4
4.9
%
1.6
1.6
0.24
84
551
(3011412) CD3 cells [#/volume] in Blood
24
98
2.47
4.05
3.0
1.9
e9/l
1.0
1.1
0.31
15
60
(3009542) Hematocrit [Volume Fraction] of Blood
1246
11668
1.25
4.04
20.3
16.2
%
38.9
38.9
0.04
777
7799
(36304419) Bacteria [Presence] in Urine
443
3732
1.25
3.91
3.3
3.1
—
—
—
0
0
(3000492) Spirometry study
150
1086
1.42
3.84
1.6
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
219
1689
1.34
3.81
1.4
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
381
3168
1.26
3.75
1.9
1.7
pmol/l
440.4
25039185.7
2.40
318
2580
(3044889) 12 lead EKG panel
1040
9589
1.22
3.75
4.6
4.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
526
4534
1.23
3.75
6.2
5.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1156
10773
1.23
3.74
22.3
18.3
%
13.9
13.8
1.51
1137
10511
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
139
1004
1.42
3.62
1.6
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
92
616
1.52
3.52
2.2
2.0
ug/l
2.6
2.5
0.04
78
549
(3000494) Fungus identified in Specimen by Culture
199
1533
1.34
3.50
1.6
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
399
3366
1.24
3.44
4.8
3.7
%
88.6
87.8
0.23
388
3281
(3000570) Elastase.pancreatic [Mass/mass] in Stool
59
358
1.67
3.41
1.5
1.4
ug/g
273.8
268.3
0.08
35
214
(3006184) Hemoglobin [Mass/volume] in Capillary blood
52
305
1.73
3.40
1.7
2.2
g/l
127.5
127.4
0.00
40
233
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
63
390
1.64
3.38
1.2
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
211
1650
1.32
3.35
1.3
1.3
titre
451.7
542.6
0.30
41
359
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
74
478
1.57
3.34
3.0
2.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
31
156
2.01
3.25
1.3
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
33
170
1.96
3.25
1.3
1.6
%
62.7
66.1
0.16
16
102
(3025941) Bacteria identified in Stool by Culture
96
666
1.47
3.13
1.4
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
268
2184
1.27
3.11
1.3
1.3
iu/ml
23.8
39.9
2.38
83
698
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
260
2118
1.27
3.02
1.3
1.2
u/ml
10.6
13.3
0.26
89
803
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
18
75
2.41
2.97
2.3
1.8
%
14.1
13.4
—
10
30
(4034850)
67
436
1.56
2.96
11.9
10.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
46
2.84
2.92
3.5
2.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
100
710
1.43
2.91
1.2
1.2
u/ml
116.0
216.0
2.13
88
647
(1175426) CD3 cells/100 lymphocytes in Blood
18
76
2.38
2.89
2.3
1.8
%
76.4
72.6
0.39
18
71
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
209
1667
1.29
2.88
3.8
4.1
u/l
240.4
251.9
0.49
192
1577
(3026493) Urate [Moles/volume] in Serum or Plasma
415
3575
1.21
2.88
2.7
2.7
umol/l
3902.9
7148.7
0.79
345
3067
(40760892) CBC W Ordered Manual Differential panel - Blood
331
2787
1.23
2.88
5.5
4.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
73
490
1.51
2.82
1.1
1.1
u/ml
1.2
2.0
—
5
6
(40768804) Tissue Pathology biopsy report
598
5346
1.18
2.74
2.2
2.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
94
670
1.43
2.70
4.4
3.8
%
46.1
48.0
0.34
94
659
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
25
126
2.00
2.66
1.7
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
27
140
1.94
2.66
1.7
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
243
1995
1.25
2.65
2.7
2.4
g/l
2.4
2.3
1.91
225
1841
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
74
506
1.48
2.64
3.9
2.6
u/ml
0.4
0.4
0.34
44
293
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
82
573
1.45
2.62
1.0
1.0
—
—
—
0
0
(3012544) pH of Venous blood
175
1382
1.30
2.62
4.3
3.4
—
7.4
—
0
5
(3052592) Norovirus Ag [Presence] in Stool
9
25
3.61
2.57
1.2
1.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
260
2166
1.24
2.49
2.7
2.4
umol/l
13.0
12.8
0.12
238
1992
(3012095) Magnesium [Moles/volume] in Serum or Plasma
270
2260
1.23
2.48
3.2
3.1
mmol/l
0.8
0.8
0.10
249
2096
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
45
279
1.63
2.47
1.4
1.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
159
1253
1.30
2.43
8.4
6.7
mmol/l
11.3
10.6
0.48
146
1184
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
161
1272
1.29
2.41
3.6
2.4
ug/l
7.4
7.0
0.06
137
1110
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
16
70
2.30
2.41
3.0
2.6
%
43.9
41.9
—
10
25
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
154
1211
1.30
2.39
2.1
2.2
u/l
32.0
38.8
1.50
126
1027
(3027945) Reticulocytes/100 erythrocytes in Blood
203
1653
1.26
2.39
2.7
2.5
%
1.7
1.8
0.86
177
1467
(3048689) Calprotectin [Mass/mass] in Stool
174
1391
1.28
2.38
2.1
2.1
ug/g
126.0
147.4
0.37
144
1076
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
52
2.51
2.36
1.2
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1382
13305
1.20
2.35
5.2
5.1
mmol/l
2.6
2.7
0.78
1262
12056
(3007164) IgA [Mass/volume] in Serum or Plasma
273
2301
1.22
2.35
1.4
1.5
g/l
2.6
2.5
0.10
165
1367
(3013512) EKG study
474
4207
1.18
2.31
4.3
4.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
21
105
2.01
2.31
1.2
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
28
3.23
2.30
2.7
3.9
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
10
35
2.87
2.30
2.5
2.1
%
14.2
10.1
—
10
30
(3017732) Neutrophils [#/volume] in Blood
115
873
1.34
2.30
3.2
3.1
e9/l
4.3
4.2
0.16
88
659
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
29
3.11
2.22
4.0
2.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
43
274
1.58
2.15
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
82
598
1.39
2.13
1.7
1.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
499
4474
1.16
2.12
5.6
5.2
ug/l
2.7
3.2
0.67
450
3969
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1348
12987
1.18
2.08
4.7
4.6
mmol/l
4.6
4.6
0.25
1247
11850
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
75
2.14
2.08
2.4
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
60
415
1.46
2.08
2.9
3.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
10
5.01
2.07
1.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
19
96
1.99
2.05
3.1
2.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
34
208
1.65
2.02
2.3
2.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
222
1863
1.22
2.01
2.8
2.5
%
21.8
22.9
0.57
180
1588
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
104
1.93
2.00
1.1
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
32
2.82
2.00
1.1
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
328
2856
1.18
2.00
2.8
2.7
mosm/kgh2o
527.0
549.4
1.23
283
2441
(3003327) Ova and parasites identified in Stool by Light microscopy
52
354
1.48
1.96
1.7
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
164
1337
1.25
1.94
4.4
3.3
mmol/l
2.1
2.0
0.07
132
1062
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
108
835
1.31
1.94
1.5
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
36
227
1.60
1.91
1.3
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
114
891
1.30
1.90
1.4
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
22
121
1.83
1.88
1.3
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
22
121
1.83
1.88
1.3
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
22
121
1.83
1.88
1.3
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
22
3.19
1.88
1.6
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
15
72
2.09
1.86
4.0
1.9
e6/l
585.9
736.0
—
9
29
(3043410) Blood group antigens tested for on Red Blood Cells
10
40
2.51
1.83
1.6
2.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
255
2189
1.19
1.83
2.8
2.9
e6/l
2.9
2.2
0.43
130
1191
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
74
546
1.37
1.83
1.8
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
403
3593
1.16
1.82
5.3
4.5
%
22.4
21.6
0.48
205
1849
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
86
650
1.34
1.82
4.0
3.5
mmol/l
23.8
24.1
0.37
70
581
(3010144) Erythrocytes [#/volume] in Synovial fluid
23
130
1.78
1.82
1.1
1.3
e6/l
14083.4
131708.8
0.92
13
90
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
17
87
1.96
1.80
1.4
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
17
87
1.96
1.80
1.4
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
169
1396
1.23
1.80
1.3
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1291
12443
1.15
1.78
4.2
4.1
mmol/l
1.2
1.3
2.22
1176
11175
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
42
281
1.51
1.75
1.7
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
18
3.34
1.74
8.8
8.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
397
3547
1.16
1.74
3.9
3.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
22
125
1.77
1.72
3.6
2.9
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
38
250
1.53
1.71
6.6
4.8
iu/ml
268.5
997.6
—
10
36
(44790049)
25
148
1.70
1.70
1.6
1.5
—
—
—
0
0
(44790047)
25
148
1.70
1.70
1.6
1.5
—
—
—
0
0
(44806118)
25
148
1.70
1.70
1.6
1.5
—
—
—
0
0
(44790048)
25
148
1.70
1.70
1.6
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1331
12874
1.15
1.68
4.6
4.5
mmol/l
1.5
1.5
4.07
1223
11654
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
110
872
1.28
1.68
4.0
3.5
mmol/l
2.0
1.9
0.17
87
660
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
48
334
1.45
1.66
1.5
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
49
343
1.44
1.65
1.4
1.6
e6/l
7951.0
18921.7
1.44
41
248
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
25
2.81
1.65
7.7
7.2
—
—
—
0
0
(3009343) pH of Capillary blood
114
911
1.27
1.63
4.1
3.5
ph
7.4
7.4
3.11
15
125
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1287
12432
1.14
1.61
6.2
6.1
mmol/mol
40.1
40.4
0.77
1193
11358
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
115
924
1.26
1.58
4.1
3.5
kpa
5.1
5.2
0.62
107
845
(3002619) Bacteria identified in Specimen by Culture
7
26
2.70
1.58
1.1
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
22
129
1.71
1.57
1.1
1.5
%
21.8
27.0
—
10
78
(3020630) Protein [Mass/volume] in Serum or Plasma
151
1253
1.22
1.56
2.5
2.6
g/l
66.4
66.4
0.01
134
1153
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
57
2.11
1.55
1.1
1.0
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
19
107
1.78
1.55
2.1
1.4
u/ml
16.0
25.8
—
7
19
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
31
200
1.56
1.54
1.2
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
24
145
1.66
1.54
1.3
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
43
298
1.45
1.54
1.4
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
77
590
1.32
1.53
2.0
1.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
98
778
1.28
1.50
1.1
1.2
iu/ml
188.3
148.0
0.29
34
288
(3022621) pH of Urine by Test strip
116
942
1.25
1.48
3.6
3.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
104
834
1.26
1.47
1.2
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
309
2747
1.15
1.46
2.7
3.0
mmol/l
2.5
2.5
0.46
271
2409
(3026250) Tacrolimus [Mass/volume] in Blood
9
38
2.38
1.45
39.9
30.1
ug/l
7.5
6.9
—
9
33
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
54
396
1.38
1.44
1.6
1.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
9
39
2.31
1.43
2.7
2.3
—
63744.7
—
0
7
(3027273) Bicarbonate [Moles/volume] in Venous blood
92
730
1.28
1.43
4.3
3.1
mmol/l
25.5
25.3
0.23
92
708
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
46
2.18
1.40
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
29
190
1.54
1.37
3.4
2.1
—
—
—
0
0
(3017704) Immunofixation for Urine
16
89
1.81
1.37
1.8
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
112
915
1.24
1.37
1.3
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
17
2.95
1.36
2.0
1.9
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
92
736
1.26
1.35
2.6
3.4
pmol/l
4.3
4.4
0.50
85
636
(3036481) Cortisol [Moles/volume] in Serum or Plasma
138
1155
1.21
1.34
2.5
2.1
nmol/l
365.3
371.8
0.14
128
1052
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
37
0.00
1.34
0.0
2.2
—
143.8
—
0
32
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
17
284
0.59
1.34
1.2
1.4
pmol/l
62.3
245.4
2.43
17
279
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
184
1.53
1.32
1.4
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
26
169
1.55
1.29
4.3
5.8
mmol/l
8.6
7.2
0.61
17
142
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
134
1124
1.21
1.28
4.3
3.6
ng/l
96.2
93.1
0.12
111
961
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
180
1552
1.18
1.27
3.3
3.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
44
2.05
1.27
1.1
1.1
miu/ml
1313.8
1622.6
—
9
44
(3044927) Protein electrophoresis panel - Urine
24
155
1.56
1.23
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
19
116
1.65
1.21
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
125
1049
1.21
1.20
2.5
2.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
25
164
1.53
1.20
1.2
1.2
u/ml
2.8
5.1
0.80
11
71
(4306422)
24
156
1.55
1.20
1.2
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
23
148
1.56
1.20
1.0
1.0
u/ml
14.1
2.2
—
6
59
(3023520) Reticulocytes [#/volume] in Blood
145
1235
1.19
1.19
2.5
2.6
e9/l
67.7
70.1
0.44
118
948
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
18
109
1.66
1.19
1.3
1.4
u/l
16.4
14.1
0.26
18
102
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
231
1.44
1.17
1.4
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
57
1.94
1.17
1.4
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
197
1726
1.16
1.16
1.3
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
64
811
0.78
1.15
1.3
1.4
—
—
—
0
0
(3019225) pH of Specimen
169
1464
1.17
1.15
4.8
4.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
16
95
1.69
1.14
1.8
1.3
—
310.9
—
0
11
(3045716) Anion gap in Serum or Plasma
12
65
1.85
1.13
3.3
1.8
mmol/l
8.4
10.0
—
7
53
(3036489) Thrombin time
60
467
1.30
1.13
2.2
2.0
s
21.8
21.3
0.31
52
419
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
30
2.34
1.12
7.7
7.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
31
2.26
1.10
1.1
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
31
2.26
1.10
1.1
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
12
66
1.82
1.09
1.2
1.2
nmol/l
139.7
138.1
0.04
12
66
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
12
66
1.82
1.09
1.0
1.1
iu/ml
8.0
11.2
—
7
10
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
387
3560
1.11
1.07
1.7
1.6
mmol/l
1.3
1.3
0.53
324
2950
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
105
1.63
1.06
1.2
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
39
288
1.36
1.05
2.8
2.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
146
1.51
1.03
1.1
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
34
2.06
1.03
1.0
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
43
325
1.33
1.01
1.5
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
72
584
1.24
1.00
1.3
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
47
361
1.31
0.99
1.7
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
13
76
1.72
0.99
2.7
3.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
29
206
1.41
0.99
1.4
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
23
2.18
0.98
1.2
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
49
380
1.30
0.97
4.4
3.7
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
30
0.00
0.97
0.0
1.3
—
61.3
—
0
25
(3006442) Creatine [Moles/volume] in Serum or Plasma
15
92
1.64
0.97
2.7
1.4
—
66.0
—
0
6
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
25
174
1.44
0.95
1.2
1.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
38
285
1.34
0.95
4.6
2.5
umol/l
42.9
34.3
0.57
33
239
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
44
338
1.31
0.94
1.5
1.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
14
85
1.65
0.94
2.1
1.8
%
51.2
43.7
—
5
10
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
30
217
1.39
0.93
1.4
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
81
672
1.22
0.92
1.4
1.8
g/l
1.5
1.6
0.32
65
585
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
55
1.82
0.92
1.2
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
91
767
1.20
0.89
3.2
3.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
27
370
0.73
0.89
1.2
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
34
254
1.35
0.88
1.4
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
42
1.91
0.88
2.0
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
42
1.91
0.88
2.1
1.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
21
144
1.46
0.87
1.8
2.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
42
325
1.30
0.87
4.5
3.6
mg/l
25.2
27.2
0.15
26
207
(1616796) Gas panel - Central venous blood
43
334
1.29
0.86
3.5
4.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
79
660
1.21
0.86
4.5
3.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
24
170
1.42
0.85
2.1
1.5
g/l
0.5
0.8
0.85
13
136
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
24
170
1.42
0.85
1.3
1.2
u/ml
2.5
2.2
—
8
49
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
31
1.94
0.84
2.7
2.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
96
1.57
0.84
1.2
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
26
188
1.39
0.83
1.3
1.4
e6/l
1300.4
1679.0
0.53
21
138
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
113
1.51
0.82
2.5
2.5
—
—
—
0
0
(3024471) HLA-A [Type]
6
32
1.88
0.82
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
13
81
1.61
0.81
1.0
1.1
u/ml
3.6
2.7
—
7
31
(3014133) Dog dander IgE Ab [Units/volume] in Serum
14
89
1.58
0.81
1.0
1.0
u/ml
1.8
2.8
—
7
32
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
188
0.64
0.80
1.0
1.1
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
33
1.82
0.79
1.2
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
17
115
1.48
0.77
1.2
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
107
1.50
0.76
1.4
1.3
—
—
—
0
0
(4133840)
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
23
166
1.39
0.75
1.2
1.4
e6/l
37123.1
94741.8
0.57
12
103
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
53
1.70
0.75
1.2
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
53
1.70
0.75
1.2
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
143
1271
1.14
0.75
2.2
2.0
g/l
0.2
0.2
0.10
128
1180
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
54
1.67
0.74
1.2
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
25
184
1.36
0.74
4.1
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
132
0.60
0.73
1.8
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
38
1.85
0.73
4.6
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
38
1.85
0.73
4.6
2.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
25
2.00
0.72
1.2
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
27
202
1.34
0.72
1.6
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
106
0.56
0.72
1.0
1.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
20
142
1.41
0.72
1.0
1.2
—
33.5
—
0
7
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
49
398
1.24
0.72
1.7
1.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
60
1.67
0.72
1.2
1.0
—
—
—
0
0
(4062490)
16
109
1.47
0.71
1.8
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
26
195
1.34
0.69
1.2
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
43
346
1.25
0.69
2.0
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
59
492
1.21
0.69
2.4
2.8
g/l
0.4
0.3
0.34
17
181
(1761482) Bacteria [#/volume] in Urine by Culture
51
419
1.22
0.68
3.5
4.6
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
27
1.85
0.68
1.2
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
19
136
1.40
0.67
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
171
1.35
0.65
1.3
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
130
1161
1.13
0.65
4.5
4.1
%
0.7
0.9
0.57
38
359
(3005033) Fetal Nuchal fold Thickness US
8
131
0.61
0.63
1.8
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
118
1050
1.13
0.63
4.5
3.9
%
0.3
0.6
2.07
26
251
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
44
360
1.23
0.63
1.2
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
19
138
1.38
0.62
1.3
1.1
u/ml
0.1
1.2
—
8
54
(3010726) Horse dander IgE Ab [Units/volume] in Serum
15
104
1.45
0.62
1.0
1.0
u/ml
3.2
1.4
—
7
23
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
20
268
0.74
0.62
1.3
1.4
nmol/l
0.8
0.9
0.35
14
221
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
31
244
1.28
0.61
1.5
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
88
1.48
0.60
1.0
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
42.7
—
0
7
(3051611) Lipemic interference index of Serum or Plasma
19
140
1.36
0.58
2.8
3.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
30
376
0.79
0.58
1.5
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
140
1267
1.11
0.58
2.4
1.7
%
1.5
1.5
0.21
132
1097
(3034426) Prothrombin time (PT)
6
35
1.72
0.57
1.5
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
15
106
1.42
0.57
1.4
1.2
g/l
3.2
2.8
—
7
77
(3024139) IgG subclass 3 [Mass/volume] in Serum
15
106
1.42
0.57
1.4
1.2
g/l
0.4
0.4
—
7
78
(3027135) IgG subclass 1 [Mass/volume] in Serum
15
106
1.42
0.57
1.4
1.2
g/l
6.7
6.9
—
7
77
(40768441) Liver Pathology biopsy report
14
98
1.43
0.56
1.7
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
72
826
0.87
0.56
1.8
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
183
1684
1.10
0.56
1.7
1.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(4015189)
6
37
1.62
0.55
1.7
2.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
16
216
0.74
0.54
1.6
1.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
11
74
1.49
0.53
15.3
16.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
135
0.66
0.51
1.7
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
40
1.50
0.51
1.3
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
40
1.50
0.51
1.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
64
1.41
0.51
1.1
1.1
—
—
—
0
0
(4268621)
15
109
1.38
0.51
2.3
2.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
75
1.47
0.50
1.2
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
75
1.47
0.50
1.2
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
75
1.47
0.50
1.2
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
75
1.47
0.50
1.2
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
53
454
1.17
0.50
1.4
1.2
u/ml
0.2
0.9
—
9
40
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
179
0.72
0.50
1.5
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
67
1.50
0.49
1.2
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
114
1032
1.11
0.49
4.7
4.1
%
0.0
0.5
0.80
28
268
(3019832) Treponema pallidum Ab [Presence] in Serum
80
710
1.13
0.48
1.5
1.6
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
7
46
1.52
0.48
2.0
2.1
e6/l
262.6
930.1
—
7
35
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
78
877
0.88
0.47
1.9
1.7
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
7
47
1.49
0.47
1.1
1.0
—
4.2
—
0
5
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
7
47
1.49
0.47
1.3
1.9
nmol/l
15.5
5.9
—
7
37
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
27
218
1.24
0.46
1.3
2.1
u/l
7058.3
3094.7
0.28
14
94
(3024928) Oxygen saturation in Venous blood
38
319
1.20
0.46
3.0
2.5
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
7
49
1.43
0.46
4.6
1.9
ug/l
17.6
188.6
—
7
41
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1274
12557
1.06
0.45
17.0
14.3
ml/min/173m2
77.4
76.8
0.48
1067
10344
(3004616) Nuclear Ab [Presence] in Serum
20
156
1.29
0.45
1.3
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
15
112
1.34
0.44
1.3
1.3
u/l
13.5
12.9
0.05
15
102
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
51
1.37
0.44
1.0
1.2
iu/ml
110.3
266.9
—
7
51
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
13
95
1.37
0.43
1.2
1.2
u/ml
0.3
1.6
—
7
45
(3010421) pH of Blood
47
405
1.17
0.43
4.8
4.5
ph
7.4
7.4
0.11
37
339
(3023420) DNA double strand Ab [Units/volume] in Serum
9
128
0.70
0.43
1.0
1.3
—
30.4
—
0
9
(3024263) Appearance of Synovial fluid
11
78
1.41
0.43
1.5
1.5
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
42
359
1.17
0.43
3.0
3.1
mmol/l
1.6
1.6
0.27
42
351
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
93
0.64
0.42
1.7
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
32
1.56
0.42
1.4
1.3
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
120
1103
1.09
0.41
4.6
4.1
%
0.1
0.1
0.13
33
329
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
59
1.36
0.41
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
59
1.36
0.41
1.1
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
49
427
1.15
0.40
2.2
1.7
mg/l
4.3
2.9
0.38
28
317
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
12
160
0.75
0.39
1.0
1.0
—
—
—
0
0
(4146454)
12
160
0.75
0.39
1.8
2.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
41
353
1.17
0.39
2.5
3.0
nmol/l
0.8
0.8
0.09
33
273
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
196
1.23
0.39
1.2
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
10
137
0.73
0.39
1.6
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
20
160
1.25
0.38
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
36
1.39
0.38
2.4
1.7
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
57
505
1.13
0.38
4.6
3.3
mg/l
64.3
172.9
0.47
45
410
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
37
1.35
0.37
2.8
1.9
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
37
1.35
0.37
2.4
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
116
1.30
0.37
6.2
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
15
116
1.30
0.37
1.7
1.6
%
10.6
11.0
0.18
15
116
(3045788) Cell count panel - Pleural fluid
19
152
1.25
0.37
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
83
754
1.11
0.37
1.3
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
70
1.29
0.36
4.8
3.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
38
328
1.16
0.36
2.4
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
368
3539
1.05
0.36
1.4
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
21
171
1.23
0.35
1.2
1.2
nmol/l
0.6
0.7
0.36
21
160
(3016879) Cocaine [Presence] in Urine
26
217
1.20
0.35
4.0
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
122
0.74
0.35
1.4
1.7
—
—
—
0
0
(4281824)
11
145
0.76
0.34
1.1
1.2
—
—
—
0
0
(44813793)
10
73
1.37
0.34
1.1
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
26
218
1.20
0.34
1.1
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
21
172
1.22
0.34
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
21
172
1.22
0.34
1.6
1.4
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
6
45
1.33
0.33
2.0
3.2
mu/l
15.8
20.3
—
6
45
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
109
1.29
0.33
1.8
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
608
5925
1.04
0.33
10.3
9.7
e9/l
0.0
0.0
0.38
506
4830
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
55
492
1.12
0.33
4.7
3.3
ratio
6.9
1.7
—
5
42
(3005988) Vibrio sp identified in Specimen by Organism specific culture
21
173
1.22
0.33
1.6
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
127
1187
1.08
0.32
4.3
4.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
129
1207
1.07
0.31
1.6
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
39
342
1.14
0.31
4.3
4.8
mmol/l
2.5
2.8
0.33
26
234
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
56
504
1.11
0.31
4.7
3.4
mg/l
35.4
48.3
0.87
44
408
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
175
1.20
0.30
1.6
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
175
1.20
0.30
1.6
1.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
11
84
1.31
0.30
1.0
1.1
—
168.0
—
0
15
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
163
0.80
0.29
1.9
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
54
487
1.11
0.29
1.6
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
57
1.23
0.29
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
43
383
1.13
0.28
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
158
1.20
0.28
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
62
1.29
0.28
1.1
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
177
1.19
0.27
1.6
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
116
0.77
0.27
1.1
1.1
—
—
—
0
0
(4027681)
8
64
1.25
0.27
1.0
1.1
—
—
—
0
0
(4035726)
127
1196
1.07
0.27
1.4
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
65
1.23
0.27
5.9
2.5
u/ml
524.9
1539.5
—
8
65
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
150
1421
1.06
0.27
1.6
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
35
309
1.14
0.27
1.3
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
439
4270
1.04
0.27
3.0
3.2
mg/l
791.8
252.1
0.98
287
2726
(3008757) Leukocyte morphology finding [Identifier] in Blood
19
159
1.20
0.26
5.3
3.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
42
376
1.12
0.26
1.3
1.6
g/l
1.1
1.2
0.66
37
359
(3027008) Opiates [Presence] in Urine
27
234
1.16
0.26
4.0
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
12
95
1.27
0.26
1.2
1.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
36
320
1.13
0.25
1.1
1.2
mg/l
588.9
503.2
0.23
36
299
(3017446) Testosterone [Moles/volume] in Serum or Plasma
89
830
1.08
0.25
2.2
2.2
nmol/l
11.3
12.7
1.05
76
732
(3028300) Cannabinoids [Presence] in Urine
27
235
1.15
0.25
4.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
75
1.20
0.25
1.0
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
75
1.20
0.25
1.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
13
159
0.82
0.24
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
13
159
0.82
0.24
1.6
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
10
78
1.28
0.24
1.6
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
13
158
0.82
0.23
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
13
158
0.82
0.23
1.6
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
38
1.32
0.23
1.4
1.6
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
38
1.32
0.23
1.8
1.3
%
25.2
20.3
—
5
27
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
40
1.25
0.22
1.6
3.3
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
17.5
—
0
11
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
3.4
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
42.8
—
0
6
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
4890.1
—
0
7
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
69
739
0.93
0.21
1.7
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
126
1.19
0.21
1.1
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
20
173
1.16
0.21
2.3
2.5
mg/l
34.3
23.6
—
7
43
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
123
0.81
0.20
2.1
1.5
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
16
187
0.85
0.20
2.1
2.1
u/ml
53.9
1446.7
0.48
16
177
(3027944) Amphetamines [Presence] in Urine
26
231
1.13
0.19
4.0
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
51
1.18
0.19
1.3
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
52
1.15
0.19
1.3
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
53
570
0.93
0.18
2.6
2.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
17
147
1.16
0.18
1.2
1.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
561
1.07
0.18
2.6
2.2
g/l
9.8
10.4
0.65
47
484
(21494890) Protein electrophoresis panel - 24 hour Urine
19
166
1.15
0.18
2.2
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
30
271
1.11
0.18
1.2
1.3
miu/ml
85.2
220.8
4.84
12
115
(3020682) Albumin/Creatinine [Ratio] in Urine
461
4523
1.03
0.17
3.6
4.0
mg/mmol
9.7
8.6
0.19
284
2876
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
91
1.21
0.17
1.6
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
62
1.13
0.17
1.1
1.3
—
—
—
0
0
(4211845)
5
66
0.76
0.17
4.2
3.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
69
1.16
0.16
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
70
1.14
0.16
4.3
7.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
33
302
1.09
0.16
1.2
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
43
463
0.93
0.16
2.5
2.0
g/l
39.5
37.2
2.27
38
405
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
92
1.20
0.16
1.6
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
47
438
1.08
0.15
1.4
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
421
4287
0.98
0.15
3.2
3.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
10
83
1.21
0.15
2.1
2.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
119
0.84
0.15
1.2
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
9
78
1.15
0.15
1.7
2.0
nmol/l
18.7
19.0
—
9
72
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
9
80
1.13
0.15
1.0
1.1
mg/l
173.9
242.7
—
9
71
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
80
1.13
0.15
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
150
0.87
0.14
1.3
1.3
nmol/l
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
83
1.08
0.14
4.1
3.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
87
0.80
0.14
1.4
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
25
275
0.91
0.14
1.6
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
11
93
1.18
0.14
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
449
4417
1.02
0.14
3.1
3.1
mmol/l
6.8
7.2
1.51
380
3674
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
48
511
0.94
0.14
2.9
2.3
g/l
1.0
1.2
0.09
41
443
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
42
392
1.07
0.14
1.7
1.6
iu/ml
0.2
1.9
—
9
80
(3016038) Potassium [Moles/volume] in Urine
8
96
0.83
0.13
1.1
1.1
mmol/l
33.8
34.1
—
8
85
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
98
0.82
0.13
1.5
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
170
0.88
0.13
1.7
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
284
0.91
0.13
4.3
3.5
%
60.4
59.0
0.25
26
284
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
23
252
0.91
0.12
3.7
2.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
36
336
1.07
0.12
1.5
1.3
iu/l
31.0
30.1
0.05
31
286
(3011288) Drugs identified in Urine by Screen method
18
162
1.11
0.12
5.4
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
24
220
1.09
0.11
2.2
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
147
0.88
0.11
1.6
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
41
386
1.06
0.11
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
126
0.87
0.11
1.5
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
124
1.13
0.11
1.1
1.0
u/ml
1.0
5.0
—
9
62
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
602
1.05
0.11
2.7
2.3
g/l
3.4
3.8
2.22
42
441
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
86
1.16
0.11
2.7
1.5
g/l
0.9
1.0
—
10
86
(3025130) Human papilloma virus identified in Specimen
10
115
0.87
0.10
2.0
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
603
1.05
0.10
2.7
2.3
g/l
7.0
7.6
1.18
43
461
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
603
1.05
0.10
2.7
2.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
125
0.88
0.10
1.1
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
128
1246
1.03
0.10
3.2
3.8
mmol/l
1.2
1.2
0.03
108
1076
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
47
447
1.05
0.10
2.5
1.6
titre
692.0
198.3
—
5
23
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
45
1.11
0.09
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
46
1.09
0.09
2.2
2.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
35
330
1.06
0.09
1.7
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
21
227
0.92
0.09
1.2
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
15
165
0.91
0.09
1.5
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
41
390
1.05
0.08
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
204
1.08
0.08
1.5
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
57
1.05
0.08
1.8
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
32
303
1.06
0.08
1.4
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
71
0.84
0.07
1.8
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
73
0.82
0.07
1.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
73
0.82
0.07
1.7
2.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
74
0.81
0.07
1.8
2.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
16
174
0.92
0.07
1.7
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
25
235
1.06
0.07
4.2
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
78
1.03
0.07
1.5
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
38
363
1.05
0.07
3.1
2.3
ug/min
53.3
100.3
1.04
26
226
(3045142) Bone marrow Pathology biopsy report
15
163
0.92
0.07
1.2
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
65
669
0.97
0.06
2.3
3.4
u/ml
25.6
70.5
3.50
65
647
(3023511) Choriogonadotropin [Units/volume] in Urine
13
119
1.09
0.06
1.1
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
90
1.11
0.05
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
90
1.11
0.05
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
90
1.11
0.05
1.0
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
564
1.03
0.05
2.8
2.3
g/l
2.7
3.2
2.60
42
451
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
178
1757
1.01
0.05
4.5
4.6
%
32.4
33.0
0.39
118
1137
(40768800) Prostate Pathology biopsy report
32
307
1.04
0.05
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
27
258
1.05
0.04
1.5
1.5
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
91
1.10
0.04
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
91
1.10
0.04
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
91
1.10
0.04
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
130
1318
0.99
0.04
1.6
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
24
251
0.96
0.04
4.1
3.3
%
0.9
1.3
0.46
18
192
(3030905) Polymorphonuclear cells [#/volume] in Blood
26
271
0.96
0.04
3.7
3.3
e9/l
4.7
4.3
0.44
26
271
(3021879) Hepatitis B virus core Ab [Presence] in Serum
78
766
1.02
0.03
1.4
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
33
319
1.04
0.03
1.2
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
33
320
1.03
0.03
1.8
2.5
%
16.9
15.8
0.89
19
164
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
112
1.07
0.03
1.8
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
16
152
1.05
0.02
3.8
3.3
%
56.4
57.1
—
9
97
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
10
107
0.93
0.02
1.3
1.1
—
40.0
—
0
5
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
30
308
0.97
0.02
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
30
308
0.97
0.02
1.5
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
15
157
0.96
0.01
1.3
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
187
0.96
0.01
1.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
20
207
0.97
0.01
2.4
2.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
257
2580
1.00
0.01
3.3
3.2
ug/l
0.9
0.8
0.27
184
1786
(3044290) Cell count panel - Cerebral spinal fluid
26
253
1.03
0.01
1.0
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
94
1.06
0.01
1.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
114
1.05
0.00
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
124
1.05
0.00
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
31
316
0.98
0.00
1.2
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
56
566
0.99
0.00
1.7
1.5
—
10.8
—
0
14
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
95
1.05
0.00
1.0
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
11
105
1.05
0.00
1.0
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
21
205
1.02
0.00
1.2
1.2
u/ml
290.4
279.8
0.07
14
126
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
215
1.02
0.00
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
15
151
0.99
0.00
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
151
0.99
0.00
1.0
1.1
—
—
—
0
0
(4094501)
35
355
0.99
0.00
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
44
435
1.01
0.00
1.6
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
31
309
1.00
0.00
1.7
1.8
iu/l
389.5
5.2
—
8
102
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
39
391
1.00
0.00
1.8
1.7
—
—
—
0
0
(1002224) Polysomnography panel
43
431
1.00
0.00
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
59
589
1.00
0.00
1.4
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
144
0.97
0.00
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
15
154
0.97
0.00
4.7
3.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
57
574
0.99
0.00
1.4
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
30
302
0.99
0.00
1.7
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
24
238
1.01
0.00
1.6
1.3
u/l
8.3
10.3
0.37
19
196
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
12
122
0.98
0.00
1.4
2.2
u/field
1.3
1.5
—
6
41
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
179
1789
1.00
0.00
1.7
1.4
—
—
—
0
0
(4024509)
14
137
1.02
0.00
1.9
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
7
71
0.99
0.00
1.6
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
71
0.99
0.00
1.3
1.2
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
81
0.99
0.00
1.0
1.6
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.2
—
0
6
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
81
0.99
0.00
1.0
1.6
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
73
0.96
0.00
2.3
2.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
130
1.00
0.00
1.6
1.1
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
5
0.00
0.00
0.0
9.2
—
9.2
—
0
5
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
70
1.00
0.00
1.3
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
7.9
—
0
5
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
6
0.00
0.00
0.0
1.2
—
8.1
—
0
6
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
65
0.92
0.00
1.8
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
56
0.89
0.00
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
7
73
0.96
0.00
1.6
1.4
nmol/l
1.2
1.2
—
7
59
(3011325) HIV 1+2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
70
1.00
0.00
1.3
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
51
0.98
0.00
1.6
1.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019298) Eosinophils/100 leukocytes in Peritoneal fluid
0
7
0.00
0.00
0.0
1.3
—
0.5
—
0
7
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
9
95
0.95
0.00
1.2
1.2
mmol/l
2.7
2.0
—
9
90

Mortality – FinRegistry

Association

Association between endpoint K11_FEMHER and mortality.

Females

Parameter HR [95% CI] p-value
K11_FEMHER 1.32 [1.19, 1.47] < 0.001
Birth year 0.994 [0.99, 1.0] 0.14

During the follow-up period (1.1.1998 — 31.12.2019), 1345 out of 4553 females with K11_FEMHER died.

Males

Parameter HR [95% CI] p-value
K11_FEMHER 1.088 [0.97, 1.22] 0.154
Birth year 0.986 [0.98, 1.0] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 907 out of 3097 males with K11_FEMHER died.

Mortality risk

Mortality risk for people of age

years, who have K11_FEMHER.

N-year risk Females Males
1 0.138% 0.184%
5 0.714% 1.181%
10 1.955% 3.021%
15 3.699% 5.616%
20 6.236% 9.907%

Relationships between endpoints

Index endpoint: K11_FEMHER – Femoral hernia

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data